Geschatte realtime
Cboe Europe
12:35:12 20-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
1.344
GBX
|
+0,52%
|
|
-6,61%
|
+13,33%
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Marktkapitalisatie
1 |
377,9
|
1.091
|
2.441
|
3.057
|
2.060
|
2.295
|
-
|
-
|
Bedrijfswaarde
1 |
-443,1
|
518,3
|
1.581
|
2.523
|
1.983
|
2.014
|
1.712
|
1.373
|
K/w-verhouding
|
2,87
x
|
-7,44
x
|
12,9
x
|
-58,9
x
|
1.508
x
|
9,13
x
|
7,01
x
|
5,38
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
0,48
x
|
1,69
x
|
3,09
x
|
3,39
x
|
1,88
x
|
1,82
x
|
1,61
x
|
1,47
x
|
Bedrijfswaarde/omzet
|
-0,56
x
|
0,8
x
|
2
x
|
2,8
x
|
1,81
x
|
1,6
x
|
1,2
x
|
0,88
x
|
Bedrijfswaarde/EBITDA
|
-2
x
|
4,89
x
|
7,83
x
|
11,2
x
|
6,88
x
|
5,41
x
|
3,79
x
|
2,57
x
|
Bedrijfswaarde/FCF
|
-2,97
x
|
-2,63
x
|
4,67
x
|
-11,1
x
|
-4,8
x
|
8,05
x
|
6,13
x
|
2,9
x
|
FCF Yield
|
-33,6%
|
-38%
|
21,4%
|
-9%
|
-20,8%
|
12,4%
|
16,3%
|
34,5%
|
Price to Book
|
-
|
-
|
-
|
61,1
x
|
-
|
10,6
x
|
4,05
x
|
2,35
x
|
Aantal aandelen (in duizenden)
|
146.153
|
146.701
|
140.437
|
136.489
|
136.551
|
135.096
|
-
|
-
|
Referentieprijs
2 |
2,586
|
7,439
|
17,38
|
22,40
|
15,08
|
16,99
|
16,99
|
16,99
|
Datum van publicatie
|
13-02-20
|
18-02-21
|
16-02-22
|
16-02-23
|
22-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Omzet
1 |
785
|
647
|
791
|
901
|
1.093
|
1.262
|
1.423
|
1.559
|
EBITDA
1 |
222
|
106
|
202
|
225
|
288
|
372,4
|
451,2
|
534,5
|
Bedrijfsresultaat (EBIT)
1 |
202
|
88
|
187
|
212
|
269
|
346,4
|
419
|
504
|
Operationele Marge
|
25,73%
|
13,6%
|
23,64%
|
23,53%
|
24,61%
|
27,44%
|
29,45%
|
32,33%
|
Resultaat voor belastingen (EBT)
1 |
180
|
-173
|
190
|
-95
|
1
|
332
|
407,2
|
543
|
Nettowinst (verlies)
1 |
134
|
-148
|
205
|
-53
|
2
|
267,8
|
341,2
|
439,8
|
Nettomarge
|
17,07%
|
-22,87%
|
25,92%
|
-5,88%
|
0,18%
|
21,22%
|
23,98%
|
28,21%
|
WPA
2 |
0,9000
|
-1,000
|
1,350
|
-0,3800
|
0,0100
|
1,860
|
2,423
|
3,160
|
Free Cash Flow
1 |
149
|
-197
|
339
|
-227
|
-413
|
250,2
|
279,4
|
473,8
|
FCF-marge
|
18,98%
|
-30,45%
|
42,86%
|
-25,19%
|
-37,79%
|
19,83%
|
19,64%
|
30,39%
|
Kasstroomconversie (ebitda)
|
67,12%
|
-
|
167,82%
|
-
|
-
|
67,19%
|
61,92%
|
88,64%
|
Kasstroomconversie (nettowinst)
|
111,19%
|
-
|
165,37%
|
-
|
-
|
93,45%
|
81,89%
|
107,73%
|
Dividend per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
13-02-20
|
18-02-21
|
16-02-22
|
16-02-23
|
22-02-24
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Omzet
1 |
222
|
-
|
221
|
253
|
276
|
271
|
293
|
284
|
305,6
|
328,2
|
344,4
|
358,8
|
362,5
|
EBITDA
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
77
|
78
|
98,5
|
112,9
|
112,5
|
109
|
Bedrijfsresultaat (EBIT)
1 |
32
|
-
|
-
|
71
|
71
|
60
|
66
|
70
|
78
|
93,75
|
105
|
107,5
|
107
|
Operationele Marge
|
14,41%
|
-
|
-
|
28,06%
|
25,72%
|
22,14%
|
22,53%
|
24,65%
|
25,52%
|
28,57%
|
30,47%
|
29,96%
|
29,52%
|
Resultaat voor belastingen (EBT)
1 |
-
|
-
|
-
|
-
|
62
|
-181
|
61
|
63
|
75,6
|
91,35
|
102,6
|
101,9
|
101,4
|
Nettowinst (verlies)
1 |
-
|
41
|
-
|
44
|
39
|
-135
|
54
|
47
|
58,65
|
70,55
|
79,6
|
78,4
|
78,1
|
Nettomarge
|
-
|
-
|
-
|
17,39%
|
14,13%
|
-49,82%
|
18,43%
|
16,55%
|
19,19%
|
21,5%
|
23,11%
|
21,85%
|
21,54%
|
WPA
2 |
-
|
0,3000
|
-
|
0,3100
|
-
|
-0,9800
|
0,3800
|
0,3400
|
0,4250
|
0,5200
|
0,5850
|
0,5800
|
0,5800
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
16-02-22
|
28-04-22
|
28-07-22
|
27-04-23
|
27-07-23
|
09-11-23
|
22-02-24
|
25-04-24
|
-
|
-
|
-
|
-
|
-
|
Fiscaal tijdperk: december |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
821
|
573
|
860
|
534
|
77
|
281
|
583
|
922
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
149
|
-197
|
339
|
-227
|
-413
|
250
|
279
|
474
|
ROE (netto-inkomsten/eigen vermogen)
|
-
|
-
|
-
|
133%
|
875%
|
206%
|
94,9%
|
56%
|
ROA (netto-inkomsten/totale activa)
|
-
|
-
|
-
|
-
|
-
|
14,2%
|
15,5%
|
14,8%
|
Totale activa
1 |
-
|
-
|
-
|
-
|
-
|
1.885
|
2.208
|
2.979
|
Nettoactief per aandeel
2 |
-
|
-
|
-
|
0,3700
|
-
|
1,600
|
4,190
|
7,220
|
Cashflow per aandeel
2 |
-
|
-
|
-
|
-
|
-
|
1,990
|
2,690
|
2,560
|
Capex
1 |
7
|
4
|
14
|
5
|
8
|
6,71
|
20,3
|
8,96
|
Capex/omzet
|
0,89%
|
0,62%
|
1,77%
|
0,55%
|
0,73%
|
0,53%
|
1,43%
|
0,57%
|
Datum van publicatie
|
13-02-20
|
18-02-21
|
16-02-22
|
16-02-23
|
22-02-24
|
-
|
-
|
-
|
Laatste slotkoers
16,99
USD Gemiddelde koersdoel
30,66
USD Spread / Gemiddelde doel +80,47% Consensus |
Vaira. 1 jan.
|
Kapi.
|
---|
| +13,33% | 2,3 mld. | | +10,49% | 8,96 mld. | | -10,76% | 5,19 mld. | | +51,58% | 4,77 mld. | | +12,50% | 4,26 mld. | | -20,70% | 2,37 mld. | | -29,65% | 2,21 mld. | | +19,51% | 2,17 mld. | | -0,50% | 1,64 mld. | | +0,55% | 1,6 mld. |
Specialiteit & Geavanceerde Farmaceutische Producten
|